跳到主要內容

Finepoint Capital LP

SEC CIK
0001608126
最新申報
2026/8/13

2022 年第 3 季持倉

持倉截至 2022/9/30,2022/11/10 申報。只含多頭部位,變化是跟 2022 年第 2 季比股數。

機構總覽
持股檔數
57
較 2022 年第 2 季 −3
總值
$3.04 億
較 2022 年第 2 季 +$1,484 萬 (+5.1%)
申報日
2022/11/10
SEC
Finepoint Capital LP 在 2022 年第 3 季的持倉
證券類別股數市值佔組合 %股數變化動作紀錄
TVTXTravere Therapeutics, Inc.COM1,028,875$2,535 萬8.3%+444,575+76.1%加碼歷史
ASTLAlgoma Steel Group Inc.COM3,716,732$2,394 萬7.9%00.0%不變歷史
PRTAProthena Corp Public Ltd CoSHS305,400$1,852 萬6.1%−152,100−33.2%減碼歷史
CYTKCytokinetics IncCOM NEW380,793$1,845 萬6.1%−38,640−9.2%減碼歷史
ACADAcadia Pharmaceuticals IncCOM1,111,030$1,818 萬6.0%+403,830+57.1%加碼歷史
APLSApellis Pharmaceuticals, Inc.COM266,090$1,817 萬6.0%−52,310−16.4%減碼歷史
ARVNArvinas, Inc.COM399,000$1,775 萬5.8%+399,000新進歷史
ISEEIVERIC bio, Inc.COM987,600$1,772 萬5.8%00.0%不變歷史
FOLDAmicus Therapeutics, Inc.COM1,688,400$1,763 萬5.8%−322,500−16.0%減碼歷史
RCUSArcus Biosciences, Inc.COM646,586$1,692 萬5.6%+111,586+20.9%加碼歷史
SAGESage Therapeutics, Inc.COM429,313$1,681 萬5.5%−46,287−9.7%減碼歷史
LKFTLakefront Biotherapeutics NVSPON ADR379,702$1,619 萬5.3%+120,302+46.4%加碼歷史
IOVAIovance Biotherapeutics, Inc.COM1,586,043$1,519 萬5.0%+625,843+65.2%加碼歷史
CERECerevel Therapeutics Holdings, Inc.COM536,901$1,517 萬5.0%+536,901新進歷史
DISH Network CORP25470MAF6NOTE 12/1–$1,322 萬4.3%–新進–
ASNDAscendis Pharma A/SSPONSORED ADR123,400$1,274 萬4.2%−36,100−22.6%減碼歷史
ARGXArgenx SESPONSORED ADR28,770$1,016 萬3.3%−24,030−45.5%減碼歷史
SWTXSpringWorks Therapeutics, Inc.COM308,092$879.0 萬2.9%+308,092新進歷史
Global Business Travel Group, Inc.37890B118*W EXP 99/99/999913,000$143.3 萬0.5%00.0%不變–
Bridgetown Holdings LtdG1355U121*W EXP 09/30/202895,000$11.6 萬<0.1%00.0%不變–
Zimmer Energy Transition Acq989570114*W EXP 06/16/202358,270$11.1 萬<0.1%00.0%不變–
Conyers Park III Acqsitn Cor21289P110*W EXP 08/12/202571,666$10.4 萬<0.1%00.0%不變–
Starry Group Holdings, Inc.85572U110*W EXP 99/99/999669,000$8.70 萬<0.1%00.0%不變–
CNDAWConcord Acquisition Corp II*W EXP 99/99/999408,333$8.60 萬<0.1%00.0%不變歷史
Churchill Capital Corp VI17143W119*W EXP 02/17/202540,000$7.60 萬<0.1%00.0%不變–
Churchill Capital Corp VII17144M110*W EXP 02/29/202548,000$7.40 萬<0.1%00.0%不變–
Summit Healthcre Acquistn CoG8566R110*W EXP 06/03/202489,999$7.40 萬<0.1%00.0%不變–
Gores Technology Partners II38287L115*W EXP 03/16/202450,691$7.20 萬<0.1%00.0%不變–
KKR Acquisition Holding I Co48253T117*W EXP 99/99/999588,547$7.10 萬<0.1%00.0%不變–
Jaws Hurricane Acquisitn Cor47201B111*W EXP 03/26/202387,249$6.50 萬<0.1%00.0%不變–
Afternext Healthtech AcquisiG01109126*W EXP 99/99/999366,666$5.90 萬<0.1%00.0%不變–
Ares Acquisition CorporationG33032122*W EXP 99/99/999504,706$5.80 萬<0.1%00.0%不變–
Fortress Value Acquisi Corp34964K116*W EXP 03/18/202306,513$5.40 萬<0.1%00.0%不變–
Churchill Capital Corp V17144T115*W EXP 10/29/202612,000$5.20 萬<0.1%00.0%不變–
Berenson Acquisition Corp. I083690115*W EXP 08/01/202862,499$4.40 萬<0.1%00.0%不變–
Skydeck Acquisition Corp.G82220115*W EXP 05/13/202361,756$4.20 萬<0.1%00.0%不變–
Compass Digital Acquisitn CoG2476C123*W EXP 09/29/202459,906$4.10 萬<0.1%00.0%不變–
Gores Technology Partners IN382870111*W EXP 03/16/202201,000$3.80 萬<0.1%00.0%不變–
Catalyst Partnrs Acquisitn CG19550121*W EXP 05/12/202336,666$3.70 萬<0.1%00.0%不變–
CLDWWCalidi Biotherapeutics, Inc.*W EXP 03/14/202655,200$3.70 萬<0.1%00.0%不變歷史
Bilander Acquisition Corp.09001T114*W EXP 05/19/202183,749$3.60 萬<0.1%00.0%不變–
Ross Acquisition Corp IIG7641C114*W EXP 02/01/202439,666$3.40 萬<0.1%00.0%不變–
Fortress Capital Acquisition CorpG36427121*W EXP 99/99/999392,000$3.10 萬<0.1%00.0%不變–
Corsair Partnering CorpG2540H116*W EXP 07/06/202334,666$2.80 萬<0.1%00.0%不變–
Swiftmerge Acquisition CorpG63836111*W EXP 12/13/202490,000$2.50 萬<0.1%00.0%不變–
Fortress Value Acquis Corp I34964G115*W EXP 12/31/202225,000$2.30 萬<0.1%00.0%不變–
Simon Property Grp Acq Holdi82880R111*W EXP 02/04/202335,200$2.20 萬<0.1%00.0%不變–
Cohn Robbins Holdings CorpG23726113*W EXP 08/28/202904,000$2.10 萬<0.1%00.0%不變–
Health Assurn Acquisition Co42226W117*W EXP 11/12/202643,000$1.90 萬<0.1%00.0%不變–
Revolution Healthcar Aq Corp76155Y116*W EXP 12/31/202432,639$1.70 萬<0.1%00.0%不變–
Home Plate Acquisition Corp43734R111*W EXP 09/30/202690,000$1.70 萬<0.1%00.0%不變–
Marblegate Acquisition Corp.56608A113*W EXP 08/31/202735,000$1.60 萬<0.1%00.0%不變–
Levere Holdings Corp.G5462L122*W EXP 03/09/202274,999$1.40 萬<0.1%00.0%不變–
Senior Connect Acquisitn Cor81723H116*W EXP 12/31/2021,014,000$1.00 萬<0.1%00.0%不變–
Warburg Pincus Captal Corp IG9460M124*W EXP 99/99/999125,000$8,000<0.1%00.0%不變–
The Music Acquisition Corp62752R118*W EXP 02/05/20275,250$3,000<0.1%00.0%不變–
Warburg Pincus Captal Corp IG9461D115*W EXP 99/99/99914,999$1,000<0.1%00.0%不變–

2022 年第 2 季之後清倉(7 檔)

2022 年第 2 季季末還持有、這份申報已經沒有的部位。

Finepoint Capital LP 在 2022 年第 2 季之後清倉的部位
證券類別2022 年第 2 季股數2022 年第 2 季市值2022 年第 2 季佔組合 %紀錄
SRPTSarepta Therapeutics, Inc.COM211,000$1,582 萬5.5%歷史
GBTGlobal Blood Therapeutics, Inc.COM474,000$1,514 萬5.2%歷史
MRTXMirati Therapeutics, Inc.COM210,200$1,411 萬4.9%歷史
RAREUltragenyx Pharmaceutical Inc.COM203,200$1,212 萬4.2%歷史
PTGXProtagonist Therapeutics, IncCOM735,126$581.5 萬2.0%歷史
Social Capital Hedosopha HLDG8251L113*W EXP 09/26/202671,000$32.2 萬0.1%–
Equity Distr Acquisition Cor29465E114*W EXP 09/09/202669,000$6.90 萬<0.1%–